These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31663664)

  • 1. Lupus anticoagulant assay cut-offs vary between reagents even when derived from a common set of normal donor plasmas.
    Moore GW; Kumano O
    J Thromb Haemost; 2020 Feb; 18(2):439-444. PubMed ID: 31663664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits.
    McGlasson DL; Fritsma GA
    Semin Thromb Hemost; 2013 Apr; 39(3):315-9. PubMed ID: 23468380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new-generation dilute Russell's viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen reagents and controls.
    Moore GW; Tugnait S; Savidge GF
    Br J Biomed Sci; 2005; 62(3):127-32. PubMed ID: 16196459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
    Moore GW; Peyrafitte M; Dunois C; Amiral J
    Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay.
    Moore GW; Foxton E; Platton S; Yartey N; White D; MacDonald SG
    J Thromb Haemost; 2023 Dec; 21(12):3539-3546. PubMed ID: 37597725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
    Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S
    J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents.
    Kumano O; Moore GW
    Thromb Res; 2023 Nov; 231():39-43. PubMed ID: 37801773
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of different methods for outlier detection and rejection when calculating cut off values for diagnosis of lupus anticoagulants.
    Chantarangkul V; Peyvandi F; Tripodi A;
    Thromb Res; 2020 Jun; 190():20-25. PubMed ID: 32272277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
    Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
    Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Moore GW; Jones PO; Platton S; Hussain N; White D; Thomas W; Rigano J; Pouplard C; Gray E; Devreese KMJ
    J Thromb Haemost; 2021 Dec; 19(12):3177-3192. PubMed ID: 34192404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT).
    Moore GW
    Methods Mol Biol; 2023; 2663():275-288. PubMed ID: 37204717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants.
    Moore GW; Savidge GF
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):279-82. PubMed ID: 15060428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples.
    Moore GW; Maloney JC; de Jager N; Dunsmore CL; Gorman DK; Polgrean RF; Bertolaccini ML
    Res Pract Thromb Haemost; 2017 Jul; 1(1):62-68. PubMed ID: 30046675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant.
    Gardiner C; MacKie IJ; Malia RG; Jones DW; Winter M; Leeming D; Taberner DA; Machin SJ; Greaves M
    Br J Haematol; 2000 Dec; 111(4):1230-5. PubMed ID: 11167766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.